These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION. MOSCHOS CB; WONG PC; SISE HS JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822 [No Abstract] [Full Text] [Related]
3. OFFICE MANAGEMENT OF THE ANTICOAGULATED PATIENT. UDALL JA Geriatrics; 1964 Jul; 19():505-10. PubMed ID: 14183246 [No Abstract] [Full Text] [Related]
4. [Comparative influence of coumadine and pindione on the prothrombin levels and coagulability index]. BUREAU DU COLOMBIER H Angeiologie; 1962; 14():25-7. PubMed ID: 13874764 [No Abstract] [Full Text] [Related]
5. [OUR EXPERIENCES WITH WARFARIN SODIUM IN THE PREVENTION OF POSTOPERATIVE THROMBOEMBOLISM AND IN THE TREATMENT OF THROMBOSIS]. ALANT O Orv Hetil; 1964 Jan; 105():72-4. PubMed ID: 14108729 [No Abstract] [Full Text] [Related]
6. SPECTROPHOTOMETRIC MODIFICATION OF THE TAME ASSAY FOR "PROTHROMBIN". HOUGH DA; LYONS LV; KOPPEL JL; OLWIN JH JAMA; 1964 Apr; 188():207-11. PubMed ID: 14113983 [No Abstract] [Full Text] [Related]
7. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time. FICHERA C Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019 [No Abstract] [Full Text] [Related]
8. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT. PYOERAELAE K Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207 [No Abstract] [Full Text] [Related]
9. NATURALLY OCCURRING SPECIES SPECIFIC INHIBITOR OF HUMAN PROTHROMBIN IN LUPUS ERYTHEMATOSUS. HOUGIE C Proc Soc Exp Biol Med; 1964 Jun; 116():359-61. PubMed ID: 14189138 [No Abstract] [Full Text] [Related]
10. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY? SAMUELSSON SM; LILIENBERG G Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757 [No Abstract] [Full Text] [Related]
11. [EFFECT OF PYRAZINAMIDE ON HEMOSTATIC FACTORS OF THE ORGANISM. (PRELIMINARY COMMUNICATION)]. OKULICZ JASINKA H; ZIERSKI M Gruzlica (1926); 1963 Jun; 31():657-61. PubMed ID: 14119447 [No Abstract] [Full Text] [Related]
12. ANTICOAGULANT THERAPY; APPRAISAL OF ITS LABORATORY CONTROL. WARE AG; STERLING RE; STRAGNELL R Angiology; 1964 Jan; 15():11-6. PubMed ID: 14104834 [No Abstract] [Full Text] [Related]
13. POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS. FOX SL JAMA; 1964 Apr; 188():320-1. PubMed ID: 14114008 [No Abstract] [Full Text] [Related]
14. [Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants]. FRANCESCON M; BUTTO M Acta Med Patav; 1952; 13(6):265-88. PubMed ID: 13039951 [No Abstract] [Full Text] [Related]
15. [CONTROL OF CAPILLARY RESISTANCE DURING ANTICOAGULANT THERAPY. (A SENSITIVE METHOD FOR THE MEASUREMENT OF CAPILLARY RESISTANCE)]. HORANYI M; KAROLYHAZY M Orv Hetil; 1964 Nov; 105():2172-4. PubMed ID: 14216801 [No Abstract] [Full Text] [Related]
17. POTENTIATION OF THE EFFECT OF ORALLY ADMINISTERED ANTICOAGULANTS BY PHENYRAMIDOL HYDROCHLORIDE. CARTER SA N Engl J Med; 1965 Aug; 273():423-6. PubMed ID: 14328106 [No Abstract] [Full Text] [Related]
18. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin. LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274 [No Abstract] [Full Text] [Related]
19. MEDICAL MANAGEMENT OF CEREBROVASCULAR DISEASES. KUHN RA Angiology; 1964 Feb; 15():103-6. PubMed ID: 14118542 [No Abstract] [Full Text] [Related]